BioSpace News Archive

Experienced Industry Leader Currently Serves as Board Director of Codiak BioSciences and Previously as Chief Financial Officer of Array Biopharma Prior to its Acquisition by Pfizer

- IONIS-PKK-L Rx met its primary and all secondary endpoints, including a mean reduction of up to 97% in HAE attacks compared to placebo

Diomics Corporation and Bonne Santé Group, Inc., through its Bonne Santé Natural Manufacturing division, today announced the execution of a strategic alliance agreement for the development, launch, and distribution of a line of Diocare™ products

AVEO Oncology Announces Addition of FOTIVDA ® (tivozanib) into National Comprehensive Cancer Network Clinical Practice Guidelines

SomaLogic, a global leader in proteomics technology, powered by a proprietary platform, the largest clinical proteomic database and next generation artificial intelligence and machine learning, and CM Life Sciences II (NASDAQ: CMIIU), a special purpose acquisition company, or SPAC, sponsored by affiliates of Casdin Capital, LLC and Corvex Management LP, today announced that they have entered into a definitive business combination agreement.

– Matinas to internally focus on its Lipid Nanocrystal (LNC) platform to improve the intracellular delivery of critical therapeutics – – Enrollment continues in second patient cohort of EnACT study of MAT2203 in cryptococcal meningitis; Data and Safety Monitoring Board (DSMB) evaluation of safety and efficacy data of key second patient cohort anticipated Q3 2021 – –

LUNGevity Foundation, the nation’s leading lung cancer-focused nonprofit organization, is pleased to announce that Amy C. Moore, PhD, will join the Foundation as its first Vice President of Global Engagement and Patient Partnerships.

Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer and infectious disease immunotherapies, today announced that the first person has been dosed under Gritstone’s “CORAL” program with its candidate COVID-19 vaccine in a Phase 1 study.

Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, and Science 37, the industry’s only Decentralized Clinical Trial Operating System™, today announced a strategic partnership to enable enhanced decentralized clinical trial delivery.

Amarin Corporation plc (NASDAQ: AMRN) today announced that the Canadian Cardiovascular Society (CCS) and the Egyptian Heart Journal (EHJ) (the official journal of the Egyptian Cardiovascular Society) have included icosapent ethyl in the 2021 Canadian Cardiovascular Society Guidelines1 and in the Egyptian Heart Journal’s Practical Guidance in Lipid Management2 respectively,